# Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

> **NCT05892744** · PHASE4 · RECRUITING · sponsor: **University of Texas at Austin** · enrollment: 50 (estimated)

## Conditions studied

- Major Depressive Disorder
- Chronic Major Depression, Recurrent

## Interventions

- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT05892744
- **Lead sponsor:** University of Texas at Austin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-30
- **Primary completion:** 2027-07-15
- **Final completion:** 2027-07-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05892744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05892744, "Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05892744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*